[ Price : $8.95]
FDA approvea a Nesher Pharmaceuticals ANDA for the first generic version of Genentechs Tamiflu (oseltamivir phosphate) for oral su...[ Price : $8.95]
FDA approves a UCB supplemental NDA for Briviact (brivaracetam) as monotherapy for partial-onset (focal) seizures in patients 16 y...[ Price : $8.95]
T2 Biosystems files a 510(k) for the T2Bacteria Panel that is designed to run on the companys T2Dx Instrument as a rapid diagnosti...[ Price : $8.95]
CDRH associate director Suzanne Schwartz says medical device manufacturers should build cyber security into their devices at the d...[ Price : $8.95]
FDA says an ICH guidance on genomic sampling and data has passed Step 4 and is being implemented.[ Price : $8.95]
Attorney Rachel Weil says a New Your federal court has ruled that a liability suit against Bayer over its Essure birth control dev...[ Price : $8.95]
FDA approves Amgens Mvasi, a biosimilar to Genentechs Avastin, for treating multiple forms of cancer.[ Price : $8.95]
FDA issues a guidance to facilitate study designs establishing performance characteristics of in vitro diagnostic devices intended...